Quest PharmaTech Inc.
OTC: QPTFF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ragupathy Madiyalakan
- Employees
- 3
- Headquarters
- Edmonton, Canada
- IPO year
- 2018
- Market cap
- $5.1M
- Website
- https://www.questpharmatech.com
Loading QPTFF…
Loading profile data…Frequently asked questions about QPTFF
What does Quest PharmaTech Inc. (QPTFF) do?
Quest PharmaTech Inc. (QPTFF), an Edmonton, Canada-based pharmaceutical firm, specializes in creating antibody-driven immunotherapeutic remedies primarily for various cancers. A cornerstone of its product pipeline is Mab AR 9.6, an advanced therapeutic candidate specifically designed to target truncated O-glycans on MUC16 for precise cancer trea...
Where does QPTFF trade?
Quest PharmaTech Inc. (QPTFF) trades on the Other OTC.
What sector is QPTFF in?
Quest PharmaTech Inc. (QPTFF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Quest PharmaTech Inc.?
Ragupathy Madiyalakan is the chief executive officer of Quest PharmaTech Inc. (QPTFF).
Where is Quest PharmaTech Inc. headquartered?
Quest PharmaTech Inc. is headquartered in Canada.
Does QPTFF pay a dividend?
Quest PharmaTech Inc. (QPTFF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did QPTFF go public?
Quest PharmaTech Inc. (QPTFF) completed its initial public offering in 2018.